ADCOF yields 1834.86% · JNJ yields 2.13%● Live data
📍 ADCOF pulled ahead of the other in Year 1
Combined, ADCOF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ADCOF + JNJ for your $10,000?
Adcore Inc. operates as an e-commerce advertising management and automation platform in the Asia-Pacific, Europe, the Middle East, Africa, and North America. The company offers smart algorithm powered automation tools for digital advertisers to enhance return on advertising investments, and scale their digital campaigns. Its product portfolio includes Feeditor that offers online shopping automation capabilities to advertisers; Views, a search engine marketing (SEM) solution used for campaign creation, intelligent bid management, SEM optimization, and reports; SEMDOC, an account auditing tool, which measures and analyzes 52 metrics; Effortless Marketing, a marketing solution for campaign creation and performance tracking; and Amphy, a 24/7 live online learning marketplace. The company serves enterprise companies, and small- and medium-sized businesses. Adcore Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
Full ADCOF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.